Wearable Sensors and Artificial Intelligence for the Diagnosis of Parkinson's Disease.

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Background/Objectives: This study explores the integration of wearable sensors and artificial intelligence (AI) for Human Activity Recognition (HAR) in the diagnosis and rehabilitation of Parkinson's disease (PD). The objective was to develop a proof-of-concept model based on internal reproducibility, without external generalization, that is capable of distinguishing pathological movements from healthy ones while ensuring clinical relevance and patient safety. Methods: Nine subjects, including eight patients with Parkinson's disease and one healthy control, were included. Motion data were collected using the Motigravity platform, which integrates inertial sensors in a controlled environment. The signals were automatically segmented into fixed-length windows, with poor-quality segments excluded through preprocessing. A hybrid CNN-LSTM (Convolutional Neural Networks-Long Short-Term Memory) model was trained to classify motion patterns, leveraging convolutional layers for spatial feature extraction and LSTM layers for temporal dependencies. The Motigravity system provided a controlled hypogravity environment for data collection and rehabilitation exercises. Results: The proposed CNN-LSTM model achieved a validation accuracy of 100%, demonstrating classification potential. The Motigravity system contributed to improved data reliability and ensured patient safety. Despite increasing class imbalance in extended experiments, the model consistently maintained perfect accuracy, suggesting strong generalizability after external validation to overcome the limitations. Conclusions: Integrating AI and wearable sensors has significant potential to improve the HAR-based classification of movement impairments and guide rehabilitation strategies in PD. While challenges such as dataset size remain, expanding real-world validation and enhancing automated segmentation could further improve clinical impact. Future research should explore larger cohorts, extend the model to other neurodegenerative diseases, and evaluate its integration into clinical rehabilitation workflows.

Related topics